BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28935257)

  • 1. Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M; Rezvani R; Farzad SA; Taghdisi SM; Abnous K; Ramezani M
    Int J Pharm; 2017 Oct; 532(1):581-594. PubMed ID: 28935257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
    Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38.
    Alibolandi M; Amel Farzad S; Mohammadi M; Abnous K; Taghdisi SM; Kalalinia F; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1003-1014. PubMed ID: 29806500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
    Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
    Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraiodothyroacetic acid-conjugated polyethylenimine for integrin receptor mediated delivery of the plasmid encoding IL-12 gene.
    Sheikhsaran F; Sadeghpour H; Khalvati B; Entezar-Almahdi E; Dehshahri A
    Colloids Surf B Biointerfaces; 2017 Feb; 150():426-436. PubMed ID: 27847224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor.
    Lee S; Kim J; Shim G; Kim S; Han SE; Kim K; Kwon IC; Choi Y; Kim YB; Kim CW; Oh YK
    J Control Release; 2012 Dec; 164(2):213-20. PubMed ID: 22664473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer.
    Shahriari M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
    J Control Release; 2021 Jul; 335():369-388. PubMed ID: 34058270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
    Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
    J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model.
    Zavvar T; Babaei M; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M
    Int J Pharm; 2020 Mar; 578():119091. PubMed ID: 32007591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted MMP-2 responsive chimeric polymersomes for therapy against colorectal cancer.
    Ramezani P; Abnous K; Taghdisi SM; Zahiri M; Ramezani M; Alibolandi M
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111135. PubMed ID: 32447200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of targeted star-shaped micelle for guided delivery of camptothecin: In vitro and in vivo evaluation.
    Sahranavard M; Shahriari M; Abnous K; Hadizadeh F; Taghdisi SM; Zolfaghari R; Ramezani M; Alibolandi M
    Mater Sci Eng C Mater Biol Appl; 2021 Dec; 131():112529. PubMed ID: 34857308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of versatile targeted lipopolymersomes for improved camptothecin efficacy against colon adenocarcinoma in vitro and in vivo.
    Zahiri M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
    Expert Opin Drug Deliv; 2021 Sep; 18(9):1309-1322. PubMed ID: 33970721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 64Cu-Labeled tetraiodothyroacetic acid-conjugated liposomes for PET imaging of tumor angiogenesis.
    Kang CM; Koo HJ; Lee S; Lee KC; Oh YK; Choe YS
    Nucl Med Biol; 2013 Nov; 40(8):1018-24. PubMed ID: 24035550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation.
    Alibolandi M; Abnous K; Mohammadi M; Hadizadeh F; Sadeghi F; Taghavi S; Jaafari MR; Ramezani M
    J Control Release; 2017 Oct; 264():228-236. PubMed ID: 28844758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of
    Kim H; Koo HJ; Ahn J; Kim JY; Choi JY; Lee KH; Kim BT; Choe YS
    Bioorg Med Chem; 2020 Jan; 28(1):115212. PubMed ID: 31761727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
    Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
    Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
    Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
    Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac.
    Sudha T; Bharali DJ; Yalcin M; Darwish NH; Coskun MD; Keating KA; Lin HY; Davis PJ; Mousa SA
    Nanomedicine (Lond); 2017 Feb; 12(3):195-205. PubMed ID: 28102776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
    Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L
    J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.